MedTrace Logo

4-methylpyrazole and Acetaminophen Metabolism

NCT03878693 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2019-09-26

No results posted yet for this study

Summary

Oxidative metabolism of APAP will be studied with and without 4-MP.

Conditions

  • Healthy Adult Volunteers

Interventions

DRUG

Fomepizole

IV 4-MP.

DRUG

APAP

Oral APAP

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2018-10-31
Completion
2018-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03878693 on ClinicalTrials.gov